GDF5 and Parkinson disease: Although the protective effects of GDF5 on dopaminergic neurons have been validated in vitro and in vivo, and the receptors and some of the signaling pathways are known, there is a need for further information regarding the molecular pathways that mediate the effects of GDF5 on mDA neurons, to facilitate the development of targeted therapeutic approaches for PD.